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 Cerebral ischemia is a serious health problem, causing disability and death worldwide. 
Therefore, it is essential to develop strategies to protect and repair the brain.  
 Recently, some studies on preconditioning started to emerge, where a toxic stimulus 
below the threshold of injury is given, inducing tolerance, preparing and strengthening the brain 
for a potential greater injury. In this project, it will be used carbon monoxide (CO) as a 
preconditioning agent, since its administration is able to produce several beneficial effects, 
namely acting as an anti-apoptotic and anti-inflammatory agent. The purpose of this work is to 
disclose CO-induced cytoprotection and the potential role of FosB associated to it. The 
experiments were developed using primary cultures of astrocytes isolated from newborn mice. 
As CO source the CO-releasing molecule CORM-A1 was used. 
 CORM-A1 showed the ability to induce FosB protein expression in astrocytes, which 
was analyzed by western blot. However, it is not know yet how this increase is mediated. 
Reactive oxygen species (ROS) signaling is involved in CO and in FosB related pathways. 
Consequently, astrocytes were pre-treated with antioxidants (β-carotene or N-acetylcysteine) for 
decreasing cellular ROS levels. In addition P2X7 receptor also appears to be associated with 
FosB activation. Thus, P2X7 inhibitor (A-438079) was added to astrocytic culture in order to 
assess if FosB increased expression could be mediated by P2X7 receptor. Nevertheless, 
inhibition of ROS signaling did not change CO-induced FosB levels, while prevention of P2X7 
activation showed a slight tendency to revert FosB expression, indicating that this pathway is 
independent on ROS but it could be mediated by P2X7 receptor. 
  Although it is still a long way to go, these results gave more insight about CO-induced 
FosB activation, which is important for understanding the molecular mechanisms underlying 
CO-induced cytoprotection. Potential therapeutic applications of CO will depend on a clear 
understanding of its pathways and would potentially allow the development of more efficient 





























































 A isquemia cerebral é um grave problema de saúde, causando incapacidade e até 
mesmo a morte a nível mundial. Desta forma, é fundamental desenvolver estratégias que 
protejam e reparem o cérebro. 
 Recentemente começaram a surgir estudos acerca do pré-condicionamento, onde um 
estímulo tóxico é administrado abaixo do limiar de toxicidade, induzindo tolerância, preparando 
e fortalecendo o cérebro para um eventual dano. Neste projecto será usado monóxido de 
carbono como agente pré-condicionante, uma vez que a sua administração é capaz de produzir 
efeitos benéficos, nomeadamente actuando como um agente anti-apoptótico e anti-inflamatório. 
Com este trabalho pretende-se estudar a citoprotecção induzida pelo CO, bem como o possível 
papel do FosB que lhe está associado. As experiências foram desenvolvidas recorrendo a 
culturas primárias de astrócitos isoladas a partir de ratos recém nascidos. Como fonte de CO 
foi usada a CO-releasing molecule CORM-A1. 
 A CORM-A1 mostrou habilidade em induzir a expressão proteica do FosB em 
astrócitos, tendo sido analisada via western blot. Contudo, ainda não se sabe exactamente 
como é que este aumento acontece. A sinalização conduzida por espécies reactivas de 
oxigénio (ROS) está envolvida em vias relacionadas com o CO e o FosB. Consequentemente, 
os astrócitos foram pré tratados com antioxidantes (β-caroteno ou N-acetilcisteína) de forma a 
diminuir os níveis celulares de ROS. Para além disso, o receptor P2X7 também parece estar 
associado com a activação do FosB. Assim, um inibidor do P2X7 (A-438079) foi adicionado à 
cultura astrocítica de modo a perceber se o aumento da expressão do FosB poderá ser 
mediado pelo receptor P2X7. Contudo, a inibição da sinalização via ROS não alterou os níveis 
de FosB induzidos pelo CO, enquanto que a prevenção da activação do P2X7 mostrou haver 
um ligeira tendência para reverter a expressão do FosB, indicando que esta via é independente 
de ROS mas que poderá ser mediada via receptor P2X7. 
 Apesar de ainda haver um longo caminho a percorrer, estes dados permitiram um 
maior entendimento acerca da activação do FosB induzida pelo CO, sendo esta importante na 
compreensão dos mecanismos moleculares subjacentes à citoprotecção induzida pelo CO. 
Possíveis aplicações terapêuticas do CO estarão dependentes de um maior entendimento das 
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1.1. Cerebral Ischemia 
 
 Cerebral ischemia is one of the major causes of brain injury, affecting millions of individuals [1]. 
It is the major cause of mortality in Portugal, and the second most common cause in the world 
[2][3]
. 
Brain injury is a serious health and medical problem, causing disability and death worldwide. 
Therefore, it is very important the development of strategies to protect and repair the brain.  
 Ischemia results from a severe reduction in blood supply to a given tissue or organ due to 
narrowing or blockage of an artery 
[4][5]
. This can lead to cell death, inflammation or tissue loss, and it 
can be caused by either an embolism or by a local thrombosis 
[4]
. 
 This type of brain damage can occur in adults or newborns, either by an ischemic stroke or 
perinatal asphyxia, respectively 
[6]
. Deprivation in oxygen and glucose delivery in brain results in the 
reduction of essential energy metabolites, like ATP and phosphocreatine 
[4][5]
. These events lead to 
oxidative stress, energy failure, cell death, inflammation and ionic perturbations 
[4-6]
. 
 Brain, and particularly neurons, is very vulnerable to an ischemic insult 
[5][7]
. Complete 
interruption of cerebral blood flow (CBF) for only 5 minutes induces neuronal cell death in many brain 
regions 
[7]
. Thus, it is very important to develop ways of treatment and prevention of this condition.  
 Many clinical trials have been made with the purpose of preventing cell death, but with little 
success 
[5]
.  This lack of success is due to many reasons, such as therapeutic window considerations, 
drug dosing and delivery 
[5]
. Currently, there is only one approved drug for adults, named tPA (tissue 
plasminogen activator). Unfortunately, it can only be effective if given within 4.5 hours after the 
beginning of stroke and it is beneficial only for a very small amount of patients 
[2][5]
. For newborns the 
standard treatment is hypothermia, which is also applied only under specific criteria and short time 
window 
[8]
. However, these both strategies are based on promotion of blood reperfusion and they are 






 The central nervous system (CNS) is formed by neurons and glial cells [9]. Neurons are the 
functional unit of the nervous system, being responsible for the electrical transmission and the 
processing of the information 
[9]
. However, glial cells have indispensable functions that support and 
protect the neurons. 
 Astrocytes are the most abundant (glial) cells in CNS 
[9][10]
 and they are responsible for the 
maintenance of brain homeostasis, either in a healthy or in a damaged brain 
[11]
. For many years, the 
neurons have been the major focus of scientists, but now, with the understanding of the functions of 
astrocytes, this neurocentric view is changing 
[10]
.  
 Astrocytes are more resistant to ischemia than neurons since they have glycogen storages 




 gradients are higher 
[10-12]
, resisting more to 
hypoglycemia and ATP depletion conditions, respectively. Because of this, they can support neuronal 
activity during these insults 
[12]
 by assuring them the minimal conditions for neurons to function. 
Besides energy supply, astrocytes can also play other essential functions in order to enhance 
neuronal survival, like detoxification of the excessive release of glutamate from neurons 
[9-11]
, reducing 
cell death by excitotoxicity. Likewise, astrocytes can also attenuate the negative effects of excessive 
reactive oxygen species (ROS) and oxidative stress
 [10]
. In addition, astrocytes are responsible for ion 





 All these astrocytic neuroprotective functions are crucial, since disturbances in these 
processes can lead to neuronal dysfunction 
[12]
, causing the worsening of cerebral damage. For this 
reason, many studies have focused on astrocytes as therapeutic targets, enhancing its functions in 





1.3. Heme Oxygenase (HO) and Carbon Monoxide (CO) 
 
 Heme oxygenase is an enzyme present in all cells [14] that is responsible for the degradation of 
heme group 
[14]
, which is a very important process in hemoglobin turnover 
[15]
. These enzymes are 
essential in the maintenance of tissue homeostasis and cytoprotection, playing an important role in the 
redox cell state 
[16]
. 
 Currently, there are two different isoforms of this enzyme: HO-1, which is an inducible form, 
and HO-2, a constitutive form
 [15-17]
. Both isoforms respond to several stress stimuli, such as oxidative 
stress, inflammation, hypoxia and heat shock 
[14][15][17][18]




 The catabolism of heme gives rise to three different products: carbon monoxide (CO), iron and 
biliverdin (Figure 1.3). This last one is converted into bilirubin by biliverdin reductase. These two 
molecules are powerful antioxidants 
[17]
, making HO an important antioxidant enzyme, in particular in 
tissues where endogenous antioxidant defenses are weak, such as the nervous system 
[19]
. Free iron 
(Fe
2+
), which is a pro-oxidant molecule and very toxic for cells, must be rapidly sequestered by ferritin 
[15]
.  
 CO has been known as a silent killer due to its ability to strongly bind to hemoglobin. Thus, it is 
able to promote hypoxia and death since it has more affinity for hemoglobin than oxygen 
[20]
. Despite 
of its toxicity, many beneficial functions of HO have been attributed to endogenously produced CO, 
such as regulation of vessel tone, smooth muscle cell proliferation, anti-inflammatory and anti-
apoptotic functions 
[17]
. For these reasons, CO is under study to be translated into clinical use 
[14]
, as a 











Figure 1.3. Catabolism of the heme group by heme oxygenase (HO). Its catabolism originates three different 
enzymatic products: Carbon monoxide, biliverdin and iron. Biliverdin is then converted into bilirubin by biliverdin 





1.4. Carbon Monoxide-Releasing Molecules (CORMs) 
 
 The direct activation of HO is not very used as a therapeutic source of its products, since this 
hyper activation can lead to an increase of intracellular iron accumulation that is very toxic for cells. 
Therefore, it is preferable to only administrate the product of interest. 
 Because of CO's therapeutic potential, different CO-delivery strategies have been developed 
in the last years. The greatest challenge is to develop strategies, which do not increase the 
carboxyhemoglobin (COHb) levels, in order to avoid blood poisoning. Therefore, it leads to the 
development of CO-releasing molecules (CORMs), which are organic and inert compounds that can 
deliver CO in a tissue-specific manner 
[14][18]
. There are different types of CORMs with specific 
molecular characteristics 
[15][18]
. In the CNS, the most studied were CORM-A1, CORM-2 and CORM-3 
[16]
. The development of drugs for the brain is highly challenging due to its complexity. The presence of 
the blood–brain barrier (BBB), a biological barrier that serves to isolate the brain, is one of the major 
limitations, since BBB prevents the entrance of several molecules. The ability of CORMs to cross the 
BBB has not been completely understood 
[16]
. 
 In this project it will be used CORM-A1 (figure 1.4). This molecule is water-soluble and 
continuously release CO in a slow manner 
[15][21]
, which can be beneficial in the treatment of chronic 
conditions that needs a careful controlled CO delivery 
[21]
. CORM-A1 releases CO in both pH and 
temperature dependent manner, having approximately 21 minutes of half-life under physiological 
conditions (37° C and pH 7.4) 
[21][22]
. Also, the released amount of CO is equivalent to the amount of 
CORM-A1 administered. From all CORMs, CORM-A1 may be the one that mimics better the natural 
function of HO 
[21]







Figure 1.4. Chemical structure of CORM-A1. CORM-A1 is a boronate compound which contains a carboxylic acid 
for CO delivery. It is water soluble and a slow releaser of CO. Its release is pH and temperature dependent, 
having 21 minutes of half-life under physiological conditions (37° C and pH 7.4)  (Adapted from 15). 
 
 
1.5. Reactive Oxygen Species (ROS) 
 
 Despite all the negative effects of ROS, it has been seen that these reactive molecules can 
also play an important signaling role, mainly in the preconditioning event driven by CO 
[17][19]
. 
Preconditioning is defined as a procedure in which a toxic stimulus (in this case CO) is given below 
the threshold of injury in order to protect or enhance tolerance of cells against a particular disease 
[19][23]
. Several effects induced by CO are dependent on ROS generation, which can signal different 
pathways, promoting tissue tolerance 
[22]
.   
4 
 
 CO is able to induce ROS generation by two main known targets: (i) acting on NAD(P)H 
oxidase in the plasmatic membrane and (ii) partially preventing cytochrome c oxidase (COX) activity, 
affecting the electron transport chain in mitochondria 
[16]
.  
 In astrocytes, CO preconditioning acts on mitochondria by a two-step response 
[16]
. Initially, 
CO slightly inhibits cytochrome c oxidase (complex IV), retarding the rate of transport chain and 
accumulating the electrons in the complex III. Consequently, the oxygen will be enzimatically reduced 
to superoxide, been converted into other types of ROS and initiating signaling events that can 
reprogram gene expression in order to confer protection (figure 1.5) 
[16][17][23]
. After 30 minutes, 
cytochrome c oxidase activity increases again 
[16]
. This shows that CO acts by partially preventing 
COX in mitochondria, which generate low amounts of ROS to induce cytoprotection, preventing the 
excessive production of ROS and oxidative stress capable of causing damage to the cells. 


















 FosB is an immediate early gene, member of Fos family genes (c-fos, fosB, fra-1 and fra-2) 
that responds to a variety of stimuli, like stress and physiological perturbations 
[24]
. Its transcription 
forms two different mRNAs, FosB and ∆FosB. This last one is a truncated version of the first one, 
originated by alternative splicing 
[24][25]
. Fos family proteins and Jun family proteins (c-Jun, JunB, or 
JunD) heterodimerize, forming the activator protein-1 (AP-1). AP-1 is a transcription factor that 
regulates the expression of multiple genes involved in cellular fate, such as cell proliferation, 





 Many studies focus on ∆FosB, since it is mostly known for its involvement in drug addiction 
mechanisms
 [26]
. However, FosB is a fundamental key player in stress tolerance and neuroprotection 
[27]
 and it was found to be present in some neurons throughout the brain cortex of rodents 
[24]
.  
 In a previous work developed in our laboratory, it was studied the effects of CO-induced 
preconditioning in gene expression in astrocytes. Among all the differentially expressed genes, FosB 
showed strong upregulation (unpublished data). However, it is unknown whether CO-induced 
increased expression of FosB is involved in the cytoprotection role of this gasotransmitter.  
 As previously seen, CO is also capable of producing low amounts of  ROS, being important 
signaling molecules for CO-induced preconditioning. Thus, one of the hypotheses is that CO promotes 
FosB expression in a ROS-dependent manner. 
 
 
1.7. P2X7 receptor 
 
 P2X7 is a purinergic receptor, member of the P2X family. There are 7 different receptors 
(P2X1-7) and they are all expressed in several cell types, including neurons and glial cells 
[28]
. These 
receptors are ligand-gated cationic channels that are activated in response to the extracellular 
adenosine 5'-triphosphate (ATP), which is a very important signaling molecule, being responsible for 
neuron-astroglial communication 
[29][30]
. P2X7, from all the P2X receptors, is the one that needs the 
greater amount of ATP in order to be stimulated (more than 100 µM) [28][29]. Activation of P2X7 can be 
prolonged or transient. In the first case, a reversible pore is formed in the membrane, allowing the 
passage of small molecules. In some circumstances, this pore formation is associated to the induction 




 Under normal conditions, P2X7 receptors have a very low density. However, they become 
dramatically upregulated under pathological conditions 
[32]
, due to a great increase of the extracellular 
ATP following a brain injury 
[29]
. Consequently, these receptors allow calcium influx, activating a variety 
of signaling processes and changing drastically the intracellular ion homeostasis 
[28][31-33]
. Thus, the 
stimulation of this receptor has been associated to several nervous system diseases, such as brain 
ischemia, since it is involved in ATP-mediated cell death, proliferation of immunocompetent cells and 
also appears to be linked to the syntheses and release of many inflammatory mediators 
[28][29][31][32]
. 
Astrocytes contain P2X7 receptors in their plasma membrane. Once activated, they may contribute for 
excitotoxicity, since their stimulation can induce glutamate release 
[34]
. 
 Despite all of this, recent studies have demonstrated that P2X7 receptors are essential for  
astrocyte-mediated ischemic tolerance 
[30]
. Y. Hirayama et al. showed that P2X7 knockout mice failed 
to exhibit ischemic tolerance after astrocytic activation by preconditioning 
[30]
. It has also been seen 
that P2X7 can regulate gene transcription by inducing the expression of FosB 
[31]
. Furthermore, CO 
can modulate the activity of P2X receptors 
[20][35]
. Based on these data, it is possible to hypothesize 
that CO-induced preconditioning may enhance astrocyte ischemic tolerance by increasing FosB 

























 Brain injury due to ischemia is a serious cause of disability and death worldwide. 
Neuroprotection and brain repair remains a great medical challenge, since pharmacological 
interventions seem to be ineffective. However, a recent strategy has becoming very popular in science 
community: preconditioning can induce cerebral tolerance and protection to a subsequent insult such 
as cerebral ischemia. The majority of studies on preconditioning have focused exclusively on neurons. 
In this project it will be used primary cultures of astrocytes to disclose CO-induced preconditioning and 
cytoprotection and the mechanism of action of FosB associated to it. To deeper understand this 
correlation, three main questions were made: 
 i) Is FosB protein expression induced by CO?  
 ii) Is the increased expression of FosB due to ROS produced by CO-induced preconditioning? 
 iii) Is P2X7 receptor involved in CO-induced FosB expression? 
 To respond to these questions, protein content from astrocytes treated or not with CO, was 
extracted and submitted to a western blot analysis. The answer to these questions will give more 
insight about this subject, opening possibilities for the future potential development of new therapeutic 

































































3. Materials and Methods 
3.1. Cell cultures 
 
 Astrocytes were isolated from newborn mice cortex (Bl6/c57 mice) with 1-3 days old. After 
dissecting the hemispheres, the meninges were carefully removed. The tissue was then washed with 
ice-cold phosphate-buffered saline (PBS), mechanically disrupted and passed through a 70 µm nylon 
cell strainer (BD Falcon
TM
) into Dulbecco's minimum essential medium (DMEM; 41966-029, Gibco
TM
) 
enriched with 20% of fetal bovine serum (FBS; 10270-106, Gibco
TM
) and 1% of penicillin/streptomycin 
solution (Pen Strep; 15140-122, Gibco
TM
). Cell suspension was then plated in T-flasks (6-8 
hemispheres/75 cm
2
) and stored within controlled conditions (humidified atmosphere of  5% of CO2 at 
37°C). After one week in culture, dark phase cells were removed from astrocytic cell layer by vigorous 
shaking. Subsequently, the medium was changed twice a week for 2 more weeks with gradual 
reduction in FBS content, 15% in the second week and 10% in the third one. The cultured astrocytes, 
after confluence, were mild trypsinized with trypsin/EDTA (0.05%; 25300-062, Gibco
TM
) and 
subcultured in 6-well plates (approximately 200,000 cells/well) and stored in the same conditions until 
full confluency. 
 
3.2. Cell Treatment 
 
 ROS studies  
 Astrocytes were treated with β-carotene (500 µM) or N-acetylcysteine (NAC; 1 µM) for 1 hour 
prior to CO treatment. After, a CO-releasing molecule (CORM-A1; 12.5 µM; Sigma) was administered 
to the cells and incubated for 40 minutes or 1 hour. Then, cells were washed with ice-cold PBS and 
submitted to protein extraction. β-carotene and NAC were used as modulators of ROS production 
induced by CO.  
 P2X7 studies 
 Astrocytes were treated with a P2X7 inhibitor (A-438079; 10 µM; Sigma) for 10 minutes, 
followed by CORM-A1 incubation (12,5 µM) for 40 minutes or 1 hour. Then, cells were washed with 
ice-cold PBS and submitted to protein extraction.  
 
3.3. Protein extraction and quantification 
 
 The proteins were extracted using Radio-Immunoprecipitation Assay (RIPA) lysis buffer (150 
mM NaCl; 50 mM Tris-HCl (pH 7.4); 5 mM Ethylene Glycol Tetraacetic Acid (EGTA); 1% Triton; 0.5% 
sodium deoxycholate (DOC); 0.1% Sodium dodecyl sulfate (SDS); 1X cocktail protease inhibitor 
(Roche, 11697498001), pH 7.5). Then the cells were scraped and stored in -20°C until used. 
 The protein content was quantified using a BCA protein assay kit (23227, Thermo, Pierce®). 
Samples were diluted in water (1:10) and incubated with BCA mix (1:50 of reagent B and A, 
respectively) for 30 minutes at 37°C. The absorvances were measured at 560 nm in a 




3.4. Western blot 
 
 Protein samples were prepared in order to have 30 µg of protein each and subjected to 
electrophoresis by a polyacrylamide resolving gel (12%) at 135 V for approximately 1,5 hour. Then, 
they were electrically transferred into a nitrocellulose blotting membrane (10600018, GE Healthcare), 
for 1 hour at 500 mA. The membranes were blocked with 5% of bovine serum albumin (BSA) or 5% of 
light milk diluted in Tris-buffered saline-Tween20® (TBS-T) for 1 hour at RT. Then membranes were 
incubated with the primary antibody anti-FosB (rabbit monoclonal; 1:333) overnight at 4°C. After that, 
membranes were washed three times with TBS-T for 15 minutes each and incubated with secondary 
antibody anti-rabbit (from donkey; 1:5000) for 1 hour at RT. The three washing steps were repeated. 
Antibody detection was performed with western ECL substrate (170-5061, BioRad; 1:1) and the 




3.5. Statistical analysis 
 
 Results were statistically analyzed using GraphPad Prism 6 software (GraphPad Software, 
















4.1. Primary cultures of astrocytes 
 
 Astrocytes are the most abundant cells in the CNS, contributing for the good functioning of 
neurons in a healthy brain. Herein it will be used primary cultures of astrocytes (figure 4.1). Astrocytes 
are more resistant than neurons to an insult, being able to give them support during an injury, assuring 
the minimal conditions for neurons to function and consequently, preventing the worsening of the 
lesion and promoting neuroprotection. Astrocytic cells are isolated from the cortex of newborn mice 











Figure 4.1.  Primary culture of astrocytes. Dark regions correspond to confluent astrocytes after three weeks in 
culture. The lighter spots represent astrocytes under stress due to lack of space and nutrients. 
 
 
 The astrocytic star-shaped form, which gives rise to its name "astro", allows their easy 
recognition. If necessary, it is possible to perform an immunohistochemical assay with a prototypical 
marker (GFAP) in order to identify astrocytes 
[12]
 and to verify the purity of cell culture. In the isolation 
procedure, the brain meninges are taken out to prevent contamination with fibroblasts and neurons 
are mechanically disrupted during the protocol. Other possible contaminants, such as microglia and 
oligodendrocytes, are detached from the astrocytic layer by vigorous shaking in the first week. In the 












4.2. CO-preconditioning induces FosB Protein expression 
 
 The base of this work is the potential correlation between CO-induced preconditioning and 
FosB expression. In a previous work developed in our laboratory, it was observed that exogenous CO 
was able to increase FosB mRNA expression in astrocytes after 40 and 60 minutes of its 
administration (data not shown). Herein, this two time points were used to study the same effect of CO 
but on FosB protein expression, in order to assess if its mRNA and protein expression would have the 
same behavior.  
 Astrocytes treated with CO during 40 minutes presented a significant increase in FosB 
expression compared to control (figure 4.2 A). In contrast, it was observed a non-significant increase 
in FosB protein expression at 60 minutes (figure 4.2 B). Nevertheless, cells treated with CO for 60 
minutes showed a decrease in expression compared to astrocytes of 40 minutes. These results are in 
agreement with the preliminary data generated in our laboratory (data not shown), showing the 











Figure 4.2. Effect of carbon monoxide in FosB protein expression in a primary culture of astrocytes. Cells were 
treated with 12.5 µM of CORM-A1 during 40 (A) or 60 minutes (B). Data are mean ± SEM from at least ten 
independent experiences, *** p <  0.001 versus control. 
 
 This confirms that CO is able to induce FosB protein expression in astrocytes during 





4.3. ROS signaling induced by CO-preconditioning is not responsible for the increase 
of FosB protein expression  
 
 One of the aims of this project was to study whether ROS generation and signaling are 
important for CO-induced increase of FosB expression. Our hypothesis suggests that ROS generation 
is somehow involved in the increase of FosB expression. To confirm this, astrocytes were treated with 
β-carotene or N-acetylcysteine (NAC) 1 hour prior CO administration. These are two powerful 
antioxidants with distinct mechanism of action. β-carotene, the most abundant carotenoid in human 
diet, acts as a direct scavenger of free radicals 
[36][37]
. In contrast, the antioxidant properties of NAC are 
assigned to its ability to increase intracellular glutathione (GSH) levels, an important component of 
cellular detoxification pathways responsible for protecting cells against oxidative stress 
[38][39]
. 
 Astrocytes treated with β-carotene or NAC followed by 40 minutes of CO treatment did not 
show any decrease on FosB protein expression compared to astrocytes treated only with CO (figure 
4.3 A and C). Therefore, CO increases FosB protein expression in a ROS-independent manner. 
Although the anti-oxidant mechanisms of action were distinct, the final result find out to be very similar. 
Following 60 minutes of CO treatment no significant change in FosB protein expression was found in 
any of the experimental conditions (figure 4.3 B and D). Indeed, after 60 minutes of CO treatment, the 









































Figure 4.3. Effect of  β-carotene and N-acetylcysteine (NAC) in FosB protein expression in a primary culture 
of astrocytes treated with carbon monoxide. Cells were treated with 12.5 µM of CORM-A1 during 40 (A and C) or 
60 minutes (B and D) after 1h of incubation with 500 µM of β-carotene (A and B) or 1 µM NAC (C and D). Data 
are mean ± SEM from at least three independent experiences, * p <  0.05 versus control. 
  
 In conclusion, the lack of statistic differences indicates that these two antioxidants have no 
effect on FosB expression, demonstrating that ROS signaling is not involved in the CO-induced 











4.4. Role of P2X7 receptor in CO-induced FosB expression  
 
 Another hypothesis for CO to promote FosB expression is via activation of P2X7 receptor, 
since it has been seen that this receptor is essential for astrocyte-mediated ischemic tolerance. Thus, 
for following this hypothesis, it was used a P2X7 inhibitor, A-438079, in order to asses if its inhibition 
would affect FosB protein expression.  
 In this experiment, astrocytes pre-treated with A-438079 and then with CO did not show any 
significant differences in FosB expression compared to control in both 40 and 60 minutes (figure 4.4). 
However, prevention of P2X7 activation showed a slight tendency to revert CO-induced FosB 





















Figure 4.4. Effect of P2X7 inhibitor (A-438079) in FosB protein expression in a primary culture of astrocytes 
treated with carbon monoxide. Cells were treated with 12.5 µM of CORM-A1 during 40 (A) or 60 minutes (B) after 
10 minutes of incubation with 10 µM of A-438079. Data are mean ± SEM from at least four independent 
experiences, * p <  0.05 versus control. 
 
 
 These results indicate that A-438079 is not able to revert the expression levels of FosB 
induced by CO. Nevertheless, it is possible to observe a slight decrease in FosB expression, 
indicating a possible involvement of P2X7 receptor in CO-induced FosB expression. To confirm this 
tendency, it would be necessary to repeat the experiment, enhancing the number of experiences, 






























 Despite being seen as a toxic and a silent killer, CO has many beneficial effects in the 
organism when administered below the threshold of injury. In vivo studies have already demonstrated 
the ability of CO to protect the brain and reduce the damage in an ischemia model 
[40]
. However, it is 
still not well known the mechanism(s) by which CO can induce tolerance and protect the brain. The 
aim of this work was to better understand the way of action of CO-preconditioning. 
 Herein it was demonstrated that CO increases FosB protein expression after 40 minutes of 
treatment, while at 60 minutes FosB expression is back to basal levels (figure 4.2). In cell culture, 
FosB mRNA present a half-life of approximately 90 minutes 
[41]
, reason why it was possible to observe 
an increase in CO-induced FosB transcription (mRNA) after 60 minutes of treatment (previous data 
generated in the laboratory). However, the same was not observed in FosB protein expression, whose 
increase was only detectable after 40 minutes of CO administration. FosB proteins have destabilizing 
elements that lead to rapid degradation by proteossomes 
[41]
. This data could explain why there is an 
increase in mRNA levels but not in protein level at 60 minutes, returning its levels to basal ones. 
  It is known that CO directly acts on mitochondria, inducing ROS production, which leads 
signaling and preconditioning. This could be one of the pathways responsible for the increase of FosB 
expression. However, neither of the antioxidants used were able to revert the effect of CO on FosB 
expression, rejecting the previous hypothesis (figure 4.3 A and C). FosB may not be increased via 
ROS, but its involvement in cytoprotection cannot be discard, since it has been demonstrated its 
potential importance in neuroprotection 
[42]
. Actually, ROS can be acting downstream FosB, affecting 
the activator protein-1 (AP-1), for example. Interestingly, NAC, one of the antioxidants used, is able to 
inhibit the activation of AP-1 
[43]
. NAC did not affect FosB expression but can act at downstream AP-1 
level. This could explain why the antioxidants were not able to decrease the expression levels of 
FosB. 
 It has already been demonstrated the importance of P2X7 receptor for astrocyte-mediated 
tolerance 
[30]
, and its interaction with FosB 
[31]
, as well as the P2X receptors with CO 
[20]
. Therefore, it 
led us to hypothesize that this receptor could be involved in CO-induced FosB increased expression. 
These molecules seem not to be related to each other since inhibition of P2X7 did not significantly 
alter FosB expression (figure 4.4 A). However, the slight reversion in CO-induced FosB expression left 
some doubts, having the need to generate more data in order to confirm this ambiguity. 
 In summary, these results have demonstrated that CO-induced FosB protein expression is 
independent on ROS signaling induced by CO preconditioning, while the involvement of P2X7 in FosB 







































6. Conclusion and Future work 
 
 Despite being negative, these data elucidated us more about the mechanisms by which CO 
induces cytoprotection. This enables us to elaborate new questions and to give a step forward into this 
subject. 
 It is now known that ROS is not responsible for CO-induced FosB expression. Its role in 
cytoprotection might follow a different pathway, but it is definitely important in CO-induced brain 
tolerance 
[44]
. P2X7 receptor seems to be involved in FosB increased expression, although these 
results are not completely enlightening and more data need to be generated.  
 In future work, it is essential to demonstrate whether FosB expression is really necessary in 
CO-induced preconditioning. Through knocking down FosB expression (using for instance siRNA 
technology), it will be possible to assess if CO still can protect against cell death or not, and to 
determine FosB importance in this cytoprotective mechanism. It also could be interesting to study the 
relevance of AP-1, inhibiting its action in order to prove its relevance for CO-cytoprotection. Since AP-
1 can be formed by other proteins belonging to c-Fos family, again, knocking down FosB could reveal 
if its increased expression induced by CO is important for the AP-1 formation or if it plays a different 
role. 
 These results gave more insight about CO-induced FosB activation, contributing for the 
disclosure of the molecular mechanisms underlying CO-induced cytoprotection. This will help in the 
future for opening possibilities for a potential application of CO as therapeutic molecule, which may 
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